The promoter construct that was used in this study has been shown to label CD11b+ myeloid cells in murine myocardial infarction models45, which would imply that a subset of the Cre+ cells that reside in the scar 30 days post ablation are myeloid or myeloid derived. This evidence concerns the gene ITGAM and myocardial infarction.